-
2023
-
Mayo Clinic cancer expert highlights advancements in treating multiple myeloma
-
Paxlovid Gets Advisory Panel Support for Full FDA Approval
-
FDA Approves Novartis Treatment Combination for Pediatric Glioma
-
FDA Offers Advice on NDAs for Postoperative Local Anesthetics
-
Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met
-
Formology Lab Gets Warning Letter for Lax Identity Testing, Other Lapses
-
Ellipses Pharma’s Acute Myeloid Leukemia Candidate Gets Orphan Drug Nod
-
Ellipses Pharma’s Acute Myeloid Leukemia Candidate Gets Orphan Drug Nod
-
Title: Satellos Bioscience Announces Further Preclinical Progress with SAT-3153 as a Potential Treatment for Duchenne Muscular Dystrophy
-
FDA Will Retain Some Guidances After End to COVID Emergency